What is the projected market valuation of the Microbiome Sequencing Services Market by 2035?

The projected market valuation for the Microbiome Sequencing Services Market is 12510.97 USD Million by 2035. Read More

Which companies are considered key players in the Microbiome Sequencing Services Market?

Key players in the market include Illumina, Thermo Fisher Scientific, Qiagen, Zymo Research, Genomatix, BGI Genomics, Novogene, Macrogen, and Oxford Nanopore Technologies. Read More

What was the market valuation of the Microbiome Sequencing Services Market in 2024?

The overall market valuation of the Microbiome Sequencing Services Market was 2083.29 USD Million in 2024. Read More

What is the expected CAGR for the Microbiome Sequencing Services Market during the forecast period 2025 - 2035?

The expected CAGR for the Microbiome Sequencing Services Market during the forecast period 2025 - 2035 is 17.7%. Read More

How does the Clinical Diagnostics segment perform in terms of market valuation?

The Clinical Diagnostics segment had a valuation of 500.0 USD Million in 2024 and is projected to reach 3000.0 USD Million by 2035. Read More

What are the key applications of microbiome sequencing services?

Key applications of microbiome sequencing services include Clinical Diagnostics, Research and Development, Personalized Medicine, Agricultural Microbiome, and Environmental Monitoring. Read More

Which technology segment is expected to show the highest growth in the Microbiome Sequencing Services Market?

The Shotgun Sequencing technology segment is expected to show the highest growth, with a valuation of 683.29 USD Million in 2024 and a projected 4110.97 USD Million by 2035. Read More

What is the market valuation for the Environmental Monitoring segment in 2024?

The Environmental Monitoring segment had a valuation of 283.29 USD Million in 2024. Read More

How does the Pharmaceuticals end-use segment compare to others in market valuation?

The Pharmaceuticals end-use segment had a valuation of 500.0 USD Million in 2024, indicating a strong position within the market. Read More

What is the projected valuation for the Agricultural Microbiome segment by 2035?

The Agricultural Microbiome segment is projected to reach a valuation of 1800.0 USD Million by 2035. Read More

Microbiome Sequencing Services Market

Microbiome Sequencing Services Market Research Report Information By Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, and Others), By Application (Gastrointestinal Diseases, Infectious Diseases, CNS Diseases, Oncology, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Forecast Period

2025 - 2035

CAGR

17.7%

2024 Market Size

$ 2,083.29 Million

2035 Market Size

$ 12,510.97 Million

Healthcare ● Updated April 2026 Report ID: MRFR/HC/6063-HCR | Pages: 160 | Author: Vikita Thakur, Rahul Gotadki

Summary Table of Contents Segmentation Methodology Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Application (USD Million) | |
  1. 4.1.1 Clinical Diagnostics | |
  2. 4.1.2 Research and Development | |
  3. 4.1.3 Personalized Medicine | |
  4. 4.1.4 Agricultural Microbiome | |
  5. 4.1.5 Environmental Monitoring |
2. 4.2 Healthcare, BY Technology (USD Million) | |
  1. 4.2.1 16S rRNA Sequencing | |
  2. 4.2.2 Whole Genome Sequencing | |
  3. 4.2.3 Metagenomic Sequencing | |
  4. 4.2.4 Shotgun Sequencing |
3. 4.3 Healthcare, BY End Use (USD Million) | |
  1. 4.3.1 Healthcare | |
  2. 4.3.2 Pharmaceuticals | |
  3. 4.3.3 Agriculture | |
  4. 4.3.4 Food and Beverage | |
  5. 4.3.5 Environmental Services |
4. 4.4 Healthcare, BY Region (USD Million) | |
  1. 4.4.1 North America | | |
    1. 4.4.1.1 US | | |
    2. 4.4.1.2 Canada | |
  2. 4.4.2 Europe | | |
    1. 4.4.2.1 Germany | | |
    2. 4.4.2.2 UK | | |
    3. 4.4.2.3 France | | |
    4. 4.4.2.4 Russia | | |
    5. 4.4.2.5 Italy | | |
    6. 4.4.2.6 Spain | | |
    7. 4.4.2.7 Rest of Europe | |
  3. 4.4.3 APAC | | |
    1. 4.4.3.1 China | | |
    2. 4.4.3.2 India | | |
    3. 4.4.3.3 Japan | | |
    4. 4.4.3.4 South Korea | | |
    5. 4.4.3.5 Malaysia | | |
    6. 4.4.3.6 Thailand | | |
    7. 4.4.3.7 Indonesia | | |
    8. 4.4.3.8 Rest of APAC | |
  4. 4.4.4 South America | | |
    1. 4.4.4.1 Brazil | | |
    2. 4.4.4.2 Mexico | | |
    3. 4.4.4.3 Argentina | | |
    4. 4.4.4.4 Rest of South America | |
  5. 4.4.5 MEA | | |
    1. 4.4.5.1 GCC Countries | | |
    2. 4.4.5.2 South Africa | | |
    3. 4.4.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Illumina (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Thermo Fisher Scientific (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Qiagen (DE) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Zymo Research (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Genomatix (DE) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 BGI Genomics (CN) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Novogene (CN) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Macrogen (KR) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 Oxford Nanopore Technologies (GB) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY APPLICATION |
7. 6.4 US MARKET ANALYSIS BY TECHNOLOGY |
8. 6.5 US MARKET ANALYSIS BY END USE |
9. 6.6 CANADA MARKET ANALYSIS BY APPLICATION |
10. 6.7 CANADA MARKET ANALYSIS BY TECHNOLOGY |
11. 6.8 CANADA MARKET ANALYSIS BY END USE |
12. 6.9 EUROPE MARKET ANALYSIS |
13. 6.10 GERMANY MARKET ANALYSIS BY APPLICATION |
14. 6.11 GERMANY MARKET ANALYSIS BY TECHNOLOGY |
15. 6.12 GERMANY MARKET ANALYSIS BY END USE |
16. 6.13 UK MARKET ANALYSIS BY APPLICATION |
17. 6.14 UK MARKET ANALYSIS BY TECHNOLOGY |
18. 6.15 UK MARKET ANALYSIS BY END USE |
19. 6.16 FRANCE MARKET ANALYSIS BY APPLICATION |
20. 6.17 FRANCE MARKET ANALYSIS BY TECHNOLOGY |
21. 6.18 FRANCE MARKET ANALYSIS BY END USE |
22. 6.19 RUSSIA MARKET ANALYSIS BY APPLICATION |
23. 6.20 RUSSIA MARKET ANALYSIS BY TECHNOLOGY |
24. 6.21 RUSSIA MARKET ANALYSIS BY END USE |
25. 6.22 ITALY MARKET ANALYSIS BY APPLICATION |
26. 6.23 ITALY MARKET ANALYSIS BY TECHNOLOGY |
27. 6.24 ITALY MARKET ANALYSIS BY END USE |
28. 6.25 SPAIN MARKET ANALYSIS BY APPLICATION |
29. 6.26 SPAIN MARKET ANALYSIS BY TECHNOLOGY |
30. 6.27 SPAIN MARKET ANALYSIS BY END USE |
31. 6.28 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
32. 6.29 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY |
33. 6.30 REST OF EUROPE MARKET ANALYSIS BY END USE |
34. 6.31 APAC MARKET ANALYSIS |
35. 6.32 CHINA MARKET ANALYSIS BY APPLICATION |
36. 6.33 CHINA MARKET ANALYSIS BY TECHNOLOGY |
37. 6.34 CHINA MARKET ANALYSIS BY END USE |
38. 6.35 INDIA MARKET ANALYSIS BY APPLICATION |
39. 6.36 INDIA MARKET ANALYSIS BY TECHNOLOGY |
40. 6.37 INDIA MARKET ANALYSIS BY END USE |
41. 6.38 JAPAN MARKET ANALYSIS BY APPLICATION |
42. 6.39 JAPAN MARKET ANALYSIS BY TECHNOLOGY |
43. 6.40 JAPAN MARKET ANALYSIS BY END USE |
44. 6.41 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
45. 6.42 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY |
46. 6.43 SOUTH KOREA MARKET ANALYSIS BY END USE |
47. 6.44 MALAYSIA MARKET ANALYSIS BY APPLICATION |
48. 6.45 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY |
49. 6.46 MALAYSIA MARKET ANALYSIS BY END USE |
50. 6.47 THAILAND MARKET ANALYSIS BY APPLICATION |
51. 6.48 THAILAND MARKET ANALYSIS BY TECHNOLOGY |
52. 6.49 THAILAND MARKET ANALYSIS BY END USE |
53. 6.50 INDONESIA MARKET ANALYSIS BY APPLICATION |
54. 6.51 INDONESIA MARKET ANALYSIS BY TECHNOLOGY |
55. 6.52 INDONESIA MARKET ANALYSIS BY END USE |
56. 6.53 REST OF APAC MARKET ANALYSIS BY APPLICATION |
57. 6.54 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY |
58. 6.55 REST OF APAC MARKET ANALYSIS BY END USE |
59. 6.56 SOUTH AMERICA MARKET ANALYSIS |
60. 6.57 BRAZIL MARKET ANALYSIS BY APPLICATION |
61. 6.58 BRAZIL MARKET ANALYSIS BY TECHNOLOGY |
62. 6.59 BRAZIL MARKET ANALYSIS BY END USE |
63. 6.60 MEXICO MARKET ANALYSIS BY APPLICATION |
64. 6.61 MEXICO MARKET ANALYSIS BY TECHNOLOGY |
65. 6.62 MEXICO MARKET ANALYSIS BY END USE |
66. 6.63 ARGENTINA MARKET ANALYSIS BY APPLICATION |
67. 6.64 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY |
68. 6.65 ARGENTINA MARKET ANALYSIS BY END USE |
69. 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
70. 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY |
71. 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE |
72. 6.69 MEA MARKET ANALYSIS |
73. 6.70 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
74. 6.71 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY |
75. 6.72 GCC COUNTRIES MARKET ANALYSIS BY END USE |
76. 6.73 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
77. 6.74 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY |
78. 6.75 SOUTH AFRICA MARKET ANALYSIS BY END USE |
79. 6.76 REST OF MEA MARKET ANALYSIS BY APPLICATION |
80. 6.77 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY |
81. 6.78 REST OF MEA MARKET ANALYSIS BY END USE |
82. 6.79 KEY BUYING CRITERIA OF HEALTHCARE |
83. 6.80 RESEARCH PROCESS OF MRFR |
84. 6.81 DRO ANALYSIS OF HEALTHCARE |
85. 6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
86. 6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
87. 6.84 SUPPLY / VALUE CHAIN: HEALTHCARE |
88. 6.85 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
89. 6.86 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million) |
90. 6.87 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE) |
91. 6.88 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million) |
92. 6.89 HEALTHCARE, BY END USE, 2024 (% SHARE) |
93. 6.90 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million) |
94. 6.91 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
95. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
96. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.2.3 BY END USE, 2025-2035 (USD Million) |
97. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.3.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.3.3 BY END USE, 2025-2035 (USD Million) |
98. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.4.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.4.3 BY END USE, 2025-2035 (USD Million) |
99. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.5.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.5.3 BY END USE, 2025-2035 (USD Million) |
100. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.6.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.6.3 BY END USE, 2025-2035 (USD Million) |
101. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.7.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.7.3 BY END USE, 2025-2035 (USD Million) |
102. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.8.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.8.3 BY END USE, 2025-2035 (USD Million) |
103. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.9.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.9.3 BY END USE, 2025-2035 (USD Million) |
104. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.10.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.10.3 BY END USE, 2025-2035 (USD Million) |
105. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.11.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.11.3 BY END USE, 2025-2035 (USD Million) |
106. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.12.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.12.3 BY END USE, 2025-2035 (USD Million) |
107. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.13.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.13.3 BY END USE, 2025-2035 (USD Million) |
108. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.14.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.14.3 BY END USE, 2025-2035 (USD Million) |
109. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.15.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.15.3 BY END USE, 2025-2035 (USD Million) |
110. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.16.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.16.3 BY END USE, 2025-2035 (USD Million) |
111. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.17.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.17.3 BY END USE, 2025-2035 (USD Million) |
112. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.18.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.18.3 BY END USE, 2025-2035 (USD Million) |
113. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.19.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.19.3 BY END USE, 2025-2035 (USD Million) |
114. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.20.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.20.3 BY END USE, 2025-2035 (USD Million) |
115. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.21.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.21.3 BY END USE, 2025-2035 (USD Million) |
116. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.22.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.22.3 BY END USE, 2025-2035 (USD Million) |
117. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.23.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.23.3 BY END USE, 2025-2035 (USD Million) |
118. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.24.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.24.3 BY END USE, 2025-2035 (USD Million) |
119. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.25.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.25.3 BY END USE, 2025-2035 (USD Million) |
120. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.26.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.26.3 BY END USE, 2025-2035 (USD Million) |
121. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.27.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.27.3 BY END USE, 2025-2035 (USD Million) |
122. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.28.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.28.3 BY END USE, 2025-2035 (USD Million) |
123. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.29.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.29.3 BY END USE, 2025-2035 (USD Million) |
124. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.30.2 BY TECHNOLOGY, 2025-2035 (USD Million) | |
  3. 7.30.3 BY END USE, 2025-2035 (USD Million) |
125. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
126. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Microbiome Sequencing Services Market Segmentation

Microbiome Sequencing Services Market By Application (USD Million, 2025-2035)

Clinical Diagnostics
Research and Development
Personalized Medicine
Agricultural Microbiome
Environmental Monitoring

Microbiome Sequencing Services Market By Technology (USD Million, 2025-2035)

16S rRNA Sequencing
Whole Genome Sequencing
Metagenomic Sequencing
Shotgun Sequencing

Microbiome Sequencing Services Market By End Use (USD Million, 2025-2035)

Microbiome Sequencing Services Market
Microbiome Sequencing Services Markets
Agriculture
Food and Beverage
Environmental Services

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”